logo-loader
Compass Pathways - Compass Pathways could secure US approval for depression drug by early 2027, Jefferies says Compass Pathways could secure US approval for depression drug by early 2027, Jefferies says

Compass Pathways (NASDAQ:CMPS) could secure US regulatory approval for its experimental...

1 week, 3 days ago

MariMed delivers record revenue quarter as branded strategy gains momentum

MariMed CEO Jon Levine joined Steve Darling from Proactive to discuss the company's strongest financial quarter to date, highlighting record revenue growth, improving margins and continued expansion of its branded cannabis portfolio.Levine said the company's latest quarter marked a...

on 08/20/2026

Join Proactive

Get ahead of the curve